thioridazine has been researched along with Basal Ganglia Diseases in 23 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study compared the therapeutic efficacy of thioridazine, loxapine, and a placebo in the treatment of behavioral disturbances in nursing home patients with dementia." | 3.66 | Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. ( Barnes, R; Gumbrecht, G; Okimoto, J; Raskind, M; Veith, R, 1982) |
| "Pimozide was also shown to be effective in a single oral dose not exceeding 16 mg." | 2.64 | Pimozide in chronic schizophrenic outpatients. ( Clark, ML; Costiloe, JP; Hill, D; Huber, WK; Wood, F, 1975) |
| " It is suggested that additional studies, carefully designed, on dosage and plasma levels could help in achieving the lowest possible therapeutic dosage and thus in minimizing side effects." | 2.37 | Blood levels of neuroleptics: state of the art. ( Simpson, GM; Yadalam, K, 1985) |
| "The effect of various antipsychotic drugs on the blockade of dopaminergic receptors in striatum and limbic forebrain was examined by establishing dose-response curves for the increase in HVA and for the antagonism of d-amphetamine-induced rotation in rats with unilateral lesions of the substantia nigra." | 1.25 | On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain. ( Dingell, JV; Hill, H; Robinson, SE; Setler, P; Stawarz, RJ; Sulser, F, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (86.96) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costentin, J | 1 |
| Miglets, AW | 1 |
| Racey, G | 1 |
| Hoffer, JL | 1 |
| Barnes, R | 1 |
| Veith, R | 1 |
| Okimoto, J | 1 |
| Raskind, M | 1 |
| Gumbrecht, G | 1 |
| Inoue, F | 1 |
| Janikowski, AM | 1 |
| Caligiuri, MP | 1 |
| Rockwell, E | 1 |
| Jeste, DV | 1 |
| Trevitt, J | 1 |
| Atherton, A | 1 |
| Aberman, J | 1 |
| Salamone, JD | 1 |
| Gabriel, E | 1 |
| Karobath, M | 1 |
| Lenz, G | 1 |
| Obukhov, GA | 1 |
| Stawarz, RJ | 1 |
| Hill, H | 1 |
| Robinson, SE | 1 |
| Setler, P | 1 |
| Dingell, JV | 1 |
| Sulser, F | 1 |
| Clark, ML | 1 |
| Huber, WK | 1 |
| Hill, D | 1 |
| Wood, F | 1 |
| Costiloe, JP | 1 |
| Swett, C | 1 |
| Chouinard, G | 1 |
| Fontaine, R | 1 |
| Simpson, GM | 1 |
| Yadalam, K | 1 |
| Ananth, J | 1 |
| Edelmuth, E | 1 |
| Dargan, B | 1 |
| Aizenberg, D | 1 |
| Shalev, A | 1 |
| Munitz, H | 1 |
| Steele, C | 1 |
| Lucas, MJ | 1 |
| Tune, L | 1 |
| Beckers, W | 1 |
| Carlsson, A | 1 |
| Snyder, SH | 1 |
| Greenberg, D | 1 |
| Yamumura, HI | 1 |
| Jus, A | 1 |
| Pineau, R | 1 |
| Jus, K | 1 |
| Villeneuve, A | 1 |
| Gautier, J | 1 |
| Pires, P | 1 |
| Drolet, A | 1 |
| Cote, M | 1 |
| Villeneuve, R | 1 |
| Bullock, RJ | 1 |
| McClelland, HA | 1 |
| Blessed, G | 1 |
| Bhate, S | 1 |
| Ali, N | 1 |
| Clarke, PA | 1 |
| Diebold, K | 1 |
1 review available for thioridazine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Blood levels of neuroleptics: state of the art.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Drug | 1985 |
4 trials available for thioridazine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Pimozide in chronic schizophrenic outpatients.
Topics: Adult; Ambulatory Care; Basal Ganglia Diseases; Chronic Disease; Consciousness Disorders; Drug Evalu | 1975 |
Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings.
Topics: Aged; Alzheimer Disease; Basal Ganglia Diseases; Drug Evaluation; Fatigue; Female; Haloperidol; Huma | 1986 |
Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
Topics: Adult; Analysis of Variance; Basal Ganglia Diseases; Body Weight; Chlorpromazine; Chronic Disease; C | 1974 |
The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients.
Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia Diseases; Behavior; Chlorpromazine; Clinical Trials | 1974 |
18 other studies available for thioridazine and Basal Ganglia Diseases
| Article | Year |
|---|---|
[Seeing a new classification of active medications in psychoses].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dopamine D2 Receptor Antagonists; Huma | 2007 |
Phenothiazine induced lingual trauma.
Topics: Adult; Basal Ganglia Diseases; Diphenhydramine; Edema; Female; Humans; Thioridazine; Tongue | 1983 |
Efficacy of antipsychotic medications in behaviorally disturbed dementia patients.
Topics: Aged; Basal Ganglia Diseases; Dementia; Dibenzoxazepines; Double-Blind Method; Female; Humans; Hypot | 1982 |
Withdrawal akinesia.
Topics: Basal Ganglia Diseases; Chlorpromazine; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Th | 1981 |
Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Antipsychotic Agents; Basal Gangli | 1998 |
Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Conditioning, Operant; Haloperidol | 1998 |
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug | 1976 |
[Prolonged action neuroleptics (review of the foreign literature)].
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Child; Chronic Diseas | 1975 |
On the significance of the increase in homovanillic acid (HVA) caused by antipsychotic drugs in corpus striatum and limbic forebrain.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Clozapine; Corpus Striatum; D | 1975 |
Drug-induced dystonia.
Topics: Adjustment Disorders; Adult; Basal Ganglia Diseases; Chlorpromazine; Chlorprothixene; Female; Fluphe | 1975 |
Letter: Fluphenazine with other antipsychotic drugs.
Topics: Basal Ganglia Diseases; Chlorpromazine; Drug Administration Schedule; Drug Therapy, Combination; Flu | 1975 |
Meige's syndrome associated with neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Female; Haloperidol; Humans; Male; Meige Syndro | 1988 |
The aftercare of the patient with the neuroleptic malignant syndrome.
Topics: Adult; Aftercare; Basal Ganglia Diseases; Electroconvulsive Therapy; Humans; Male; Methotrimeprazine | 1985 |
[Gilles de la Tourette's disease based on five own observations].
Topics: Adolescent; Adult; Basal Ganglia Diseases; Compulsive Behavior; Diazepam; Dibenzocycloheptenes; Echo | 1973 |
Antipsychotic drugs and catecholamine synapses.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Brain; Catecholamines; Chlorprom | 1974 |
Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Brain; Chlorpromazine; | 1974 |
Efficacy of thiopropazate dihydrochloride (Dartalan) in treating persisting phenothiazine-induced choreo-athetosis and akathisia.
Topics: Aged; Antipsychotic Agents; Athetosis; Basal Ganglia Diseases; Chlorpromazine; Chorea; Female; Human | 1972 |
[Polythymolepsy (combined use of thymoleptics) in cases of endogenous depression].
Topics: Amitriptyline; Antidepressive Agents; Basal Ganglia Diseases; Depression; Dibenzazepines; Drug Thera | 1971 |